Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acute Respiratory Distress Syndrome
23%
Artificial Respiration
38%
Asthma
24%
Atypical Mycobacterium
24%
Biopsy Technique
15%
Body Mass Index
24%
Bronchoscopy
15%
Chronic Obstructive Pulmonary Disease
45%
Clinical Feature
32%
Computer Assisted Tomography
70%
Coughing
13%
Dyspnea
20%
Elderly Patient
25%
Epidermal Growth Factor Receptor
21%
Epidermal Growth Factor Receptor Kinase Inhibitor
15%
Erlotinib
16%
Forced Expiratory Volume
16%
Gefitinib
21%
Hazard Ratio
53%
Idiopathic Interstitial Pneumonia
29%
Idiopathic Pulmonary Fibrosis
13%
Influenza A (H1N1)
19%
Levofloxacin
19%
Low Drug Dose
15%
Lung
78%
Lung Adenocarcinoma
39%
Lung Biopsy
18%
Lung Cancer
57%
Lung Lesion
13%
Lung Nodule
16%
Lung Tuberculosis
100%
Medical Record
16%
Multidrug Resistant Tuberculosis
19%
Non Small Cell Lung Cancer
62%
Odds Ratio
46%
Patient Referral
17%
Pneumonia
13%
Prevalence
18%
Primary Tumor
21%
Prognostic Factor
77%
Pulmonary Embolism
21%
Retrospective Cohort Study
21%
Silo-Filler's Disease
35%
Sputum
19%
Stenosis
26%
Stenting
21%
Thorax Radiography
17%
Transthoracic Biopsy
14%
Tuberculosis
33%
Tuberculosis Treatment
19%
Pharmacology, Toxicology and Pharmaceutical Science
Actinomycosis
9%
Acute Respiratory Failure
29%
Adult Respiratory Distress Syndrome
10%
Afatinib
5%
Allergic Reaction
9%
Asthma
16%
Atelectasis
6%
Chemotherapy Regimens
6%
Chronic Obstructive Lung Disease
34%
Clinical Feature
17%
Community Acquired Pneumonia
14%
Coughing
6%
CYP2E1
9%
Dyspnea
8%
Epidermal Growth Factor Receptor
21%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Erlotinib
21%
Gefitinib
26%
Hemoptysis
11%
Hepatotoxicity
9%
Hospital Mortality
9%
Influenza A (H1N1)
6%
Influenza A Virus (H1N1)
9%
Interleukin 2
7%
Levofloxacin
19%
Lung Adenocarcinoma
29%
Lung Cancer
19%
Lung Embolism
14%
Lung Tuberculosis
47%
Malignant Neoplasm
9%
Moxifloxacin
9%
Multi-Drug-Resistant Tuberculosis
9%
Non Small Cell Lung Cancer
38%
Oseltamivir
9%
Overall Survival
8%
Paclitaxel
9%
Pleura Effusion
5%
Pneumonia
8%
Pranlukast
9%
Prevalence
20%
Progression Free Survival
7%
Reflux Esophagitis
9%
Small Cell Lung Cancer
9%
Spontaneous Pneumothorax
9%
Stenosis
16%
Topotecan
9%
Tuberculosis
10%
Tuberculostatic Agent
10%
Nursing and Health Professions
Acute Cholecystitis
9%
Acute Respiratory Failure
17%
Anticancer
6%
Antimicrobial Agent
6%
Artificial Respiration
19%
Body Mass
21%
Clinical Feature
16%
Clinical Outcome
20%
Cohort Analysis
6%
Computer Assisted Tomography
8%
Confidence Interval
47%
Elderly Patient
20%
Femur Fracture
9%
Fibrosing Alveolitis
9%
Forced Expiratory Volume
12%
Grip Strength
9%
Hand Grip Strength
9%
Hazard Ratio
32%
Hospital Mortality
7%
Intensive Care
5%
Intensive Care Unit
29%
Long Term Care
9%
Lung Cancer
22%
Lung Nodule
9%
Lung Tuberculosis
11%
Multivariate Analysis
6%
Non Small Cell Lung Cancer
29%
Obstructive Lung Disease
24%
Odds Ratio
22%
Pneumonia
12%
Prevalence
11%
Proportional Hazards Model
12%
Systolic Blood Pressure
9%
Tertiary Care Center
14%
Tuberculosis
9%